TY - JOUR
T1 - Proceedings from the Neurotherapeutics Symposium on Neurological Emergencies
T2 - Shaping the Future of Neurocritical Care
AU - the Neurotherapeutics Symposium 2019
AU - Simpkins, Alexis N.
AU - Busl, Katharina M.
AU - Amorim, Edilberto
AU - Barnett-Tapia, Carolina
AU - Cervenka, Mackenzie C.
AU - Dhakar, Monica B.
AU - Etherton, Mark R.
AU - Fung, Celia
AU - Griggs, Robert
AU - Holloway, Robert G.
AU - Kelly, Adam G.
AU - Khan, Imad R.
AU - Lizarraga, Karlo J.
AU - Madagan, Hannah G.
AU - Onweni, Chidinma L.
AU - Mestre, Humberto
AU - Rabinstein, Alejandro A.
AU - Rubinos, Clio
AU - Dionisio-Santos, Dawling A.
AU - Youn, Teddy S.
AU - Merck, Lisa H.
AU - Maciel, Carolina B.
AU - Brown, Jeremy
AU - Busl, Katharina M.
AU - Cervenka, Mackenzie
AU - Claassen, Jan
AU - Dhakar, Monica
AU - Dylla, Layne
AU - Elie, Marie Carmelle
AU - Etherton, Mark
AU - Fiscella, Kevin
AU - Foreman, Brandon
AU - Forgacs, Peter
AU - Griggs, Robert C.
AU - Halterman, Marc
AU - Harriott, Andrea
AU - Hirsch, Lawrence J.
AU - Hocker, Sara
AU - Holloway, Robert
AU - Jules, Rebecca
AU - Kelly, Adam G.
AU - Lackland, Daniel
AU - Lerario, Mackenzie P.
AU - Lizarraga, Karlo J.
AU - Maciel, Carolina B.
AU - Merck, Lisa H.
AU - Mitchell, Gordon
AU - Ngwenya, Laura B.
AU - Nogueira, Raul G.
AU - Pierre, Clifford
N1 - Funding Information:
High-impact translational research is essential for the development of novel therapeutic approaches in neurocritical care. Although it is well known that diversity improves productivity in team science [–], there is still a prominent imbalance in the representation of diverse backgrounds and gender in the neuroscience workforce [–] and in scientific conferences [, ]. “The Neurotherapeutics Symposium 2019—Neurological Emergencies” was designed to address these challenges by creating a platform to facilitate the discussion of innovative translational approaches in acute neurologic illnesses, while specifically seeking the participation of women and under represented minorities in the conference planning and development processes. This 2-day conference was co-hosted by the University of Florida and University of Rochester and was funded by NINDS (R13 NS11956-01), the McKnight Brain Institute, and industry (detailed support is listed under funding section); no funding party provided input in the development of scientific content of the conference or in the proceedings. The symposium was endorsed by the Neurocritical Care Society and adds to the efforts promoting inclusion in the Neurocritical Care Research Network conferences []. A total of 90 participants from 25 institutions attended the conference, including 30 from under represented groups, and 42 women. The conference was comprised of 16 lectures, 6 discussion sessions, 2 workshops, a guided poster session, and 4 networking dinner/lunch gatherings. Each lecture was followed by interactive group sessions termed “Looking into the Future,” which sourced participants for next steps in the translational process and were facilitated by pairs of early and established investigators. Opportunities for mentoring and networking between scientists at various career stages were weaved into the curriculum throughout the conference. Digital technology, using an electronic conference ‘app’, also promoted networking among attendees, while hosting a digital repository of e-posters, online discussions, and links to relevant manuscripts.
Funding Information:
We believe that facilitating such collaborative research has the potential to contribute to the development of long-term networking resources that nurture diversity in team science. Targeted fostering has shown initial success in an example of a women science database []. The talent represented by the high proportion of participants in this symposium from under represented groups, extended an opportunity to foster long-lasting mentorship relationships and career building for early career investigators. This is especially important as data support a persistent gap in racial and ethnic representation in the medical education pipeline []. Further, while the number of scholars of under represented background has grown, reflecting the establishment of an effective pipeline, attrition throughout their careers remains a significant factor that challenges the sustainability of inclusion efforts; this is supported by the lower proportion of grant funding and awards among these groups [, , ]. Our goals were aligned with the Neurocritical Care Society’s stated goals for Diversity, Equity & Inclusion [].
Funding Information:
We appreciate the contribution and presentations from the speakers and moderators at the conference, including: Edilberto Amorim, MD (University of California San Francisco, Harvard Medical School, Massachusetts Institute of Technology); Carolina Barnett-Tapia, MD, PhD (University Health Network?Toronto General Hospital); Jeremy Brown, MD (Office of Emergency Care Research NIH); Katharina M. Busl, MD, MS (University of Florida); Mackenzie Cervenka, MD (Johns Hopkins University); Jan Claassen, MD, PhD (Columbia University Medical Center); Monica Dhakar, MD, MS (Emory University); Layne Dylla, MD (University of Rochester); Marie-Carmelle Elie, MD, RDMS (University of Florida); Mark Etherton, MD, PhD (Harvard Medical School); Kevin Fiscella, MD, MPH (University of Rochester); Brandon Foreman, MD (University of Cincinnati); Peter Forgacs, MD (Weill Cornell Medical College); Robert C Griggs (University of Rochester); Marc Halterman, MD, PhD (University of Rochester); Andrea Harriott, MD, PhD (Harvard Medical School); Lawrence J Hirsch (Yale University); Sara Hocker, MD (Mayo Clinic); Robert Holloway (University of Rochester); Rebecca Jules (University of Florida); Adam G. Kelly (University of Rochester); Daniel Lackland, Dr. PH (Medical University of South Carolina); Mackenzie P Lerario, MD (Weill Cornell Medical College); Karlo J. Lizarraga, MD, MS (University of Rochester); Carolina B. Maciel, MD, MSCR (University of Florida, University of Utah, Yale University); Lisa H. Merck, MD, MPH (University of Florida); Gordon Mitchell, PhD (University of Florida); Laura B. Ngwenya, MD, PhD (University of Cincinnati); Raul G. Nogueira, MD (Emory University); Clifford Pierre, MD (University of Rochester); Javier Provencio, MD, PhD (University of Virginia); Alejandro A. Rabenstein, MD (Mayo Clinic); Debra Roberts, MD, PhD (University of Rochester); Clio Rubinos, MD (University of North Carolina); Eugene Scharf, MD (Mayo Clinic); Kevin N. Sheth, MD (Yale University); Alexis N. Simpkins, MD, PhD, MSCR (University of Florida); Cleopatra Thurman, MD (University of Michigan); Lauren Ullrich, MS, PhD (NINDS); Christopher Zammit, MD (University of Rochester). We also want to thank Franklin D. Echevarria, PhD (University of Florida) for assistance with manuscript submission and formatting.
Publisher Copyright:
© 2020, The Author(s).
PY - 2020/12
Y1 - 2020/12
N2 - Effective treatment options for patients with life-threatening neurological disorders are limited. To address this unmet need, high-impact translational research is essential for the advancement and development of novel therapeutic approaches in neurocritical care. “The Neurotherapeutics Symposium 2019—Neurological Emergencies” conference, held in Rochester, New York, in June 2019, was designed to accelerate translation of neurocritical care research via transdisciplinary team science and diversity enhancement. Diversity excellence in the neuroscience workforce brings innovative and creative perspectives, and team science broadens the scientific approach by incorporating views from multiple stakeholders. Both are essential components needed to address complex scientific questions. Under represented minorities and women were involved in the organization of the conference and accounted for 30–40% of speakers, moderators, and attendees. Participants represented a diverse group of stakeholders committed to translational research. Topics discussed at the conference included acute ischemic and hemorrhagic strokes, neurogenic respiratory dysregulation, seizures and status epilepticus, brain telemetry, neuroprognostication, disorders of consciousness, and multimodal monitoring. In these proceedings, we summarize the topics covered at the conference and suggest the groundwork for future high-yield research in neurologic emergencies.
AB - Effective treatment options for patients with life-threatening neurological disorders are limited. To address this unmet need, high-impact translational research is essential for the advancement and development of novel therapeutic approaches in neurocritical care. “The Neurotherapeutics Symposium 2019—Neurological Emergencies” conference, held in Rochester, New York, in June 2019, was designed to accelerate translation of neurocritical care research via transdisciplinary team science and diversity enhancement. Diversity excellence in the neuroscience workforce brings innovative and creative perspectives, and team science broadens the scientific approach by incorporating views from multiple stakeholders. Both are essential components needed to address complex scientific questions. Under represented minorities and women were involved in the organization of the conference and accounted for 30–40% of speakers, moderators, and attendees. Participants represented a diverse group of stakeholders committed to translational research. Topics discussed at the conference included acute ischemic and hemorrhagic strokes, neurogenic respiratory dysregulation, seizures and status epilepticus, brain telemetry, neuroprognostication, disorders of consciousness, and multimodal monitoring. In these proceedings, we summarize the topics covered at the conference and suggest the groundwork for future high-yield research in neurologic emergencies.
KW - Conference proceedings
KW - Diversity excellence
KW - Neurocritical care
KW - Team science
KW - Translational research
UR - http://www.scopus.com/inward/record.url?scp=85095689448&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85095689448&partnerID=8YFLogxK
U2 - 10.1007/s12028-020-01085-0
DO - 10.1007/s12028-020-01085-0
M3 - Article
C2 - 32959201
AN - SCOPUS:85095689448
SN - 1541-6933
VL - 33
SP - 636
EP - 645
JO - Neurocritical Care
JF - Neurocritical Care
IS - 3
ER -